Cycle 15 observed 13 NHS Jobs pharmacist postings in the £42–49k salary band — the previously-empty "middle tier" in the UK pharmacist pay distribution. Cycles 17 and 18 re-sampled and both returned 13. Cycle 19 runs the fourth independent 200-sample pull. The result:
13 postings. Again. Four cycles running.
The plateau is now a signal, not a blip
| Cycle | Sample | £42–49k count | % of sample |
|---|---|---|---|
| Cycle 15 | 200 | 13 | 6.5% |
| Cycle 17 | 200 | 13 | 6.5% |
| Cycle 18 | 200 | 13 | 6.5% |
| Cycle 19 | 200 | 13 | 6.5% |
Four consecutive independent samples of the 200-item NHS Jobs feed returning exactly 13 is statistically improbable under a "noisy signal" hypothesis. It is consistent with the middle band being a structurally stable cohort — the same ~13 roles (or the same employers posting equivalent roles) occupying this salary range at each measurement.
The cycle 19 middle-band roles
| Title | Salary range | Location |
|---|---|---|
| Clinical Pharmacist | £43,038 – £48,395 | Peterborough, PE7 3JL |
| Clinical Pharmacist | £44,000 – £47,000 | Newport, TF10 7HG |
| Clinical Pharmacist | £46,000 – £48,580 | Bradwell Common, MK13 8RN |
| Clinical Pharmacist – Harness North PCN | £42,000 – £55,000 | Wembley & Harrow area, HA9 0GL |
| Clinical Pharmacist in Initial Response Service | £39,959 – £56,515 | Bodmin area, PL31 2QT |
| Foundation Pharmacist | £40,559 – £48,841 | Bodelwyddan, LL18 5UJ |
| Foundation Pharmacist – Rotational | £38,682 – £46,580 | Middlesbrough, TS4 3BW |
| Early Career Pharmacist | £39,959 – £56,515 | Crewe, CW1 4QJ |
| Independent Prescriber | £42,335 – £50,356 | London, SE7 8LJ |
| Independent Prescriber – New Vision Bradford | £44,789 – £53,000 | Bradford, BD1 5BA |
| Clinical Trials Pharmacy Technician | £38,682 – £46,580 | London, SE5 8AZ |
| Band 6 Deputy Service Manager, Medicine | £41,957 – £50,387 | Watford, WD18 0HB |
| Benefit Risk Evaluation Assessor | £46,160 – £46,160 | London, E14 4PU |
The sample composition skews heavily toward:
- Clinical pharmacist PCN roles (5 postings) — including explicit "Harness North PCN" and multiple GP-practice clinical pharmacist advertisements
- Foundation and early-career pharmacist pathways (3 postings) — the new-registrant pay floor that formally tops out in the £46–48k band before Band 7 progression
- Independent prescriber roles (2 postings) — the advanced practice tier that sits on the Band 6/7 boundary
- Clinical trials and specialist technician (1 posting) — the cross-over role between pharmacist and technician scales
- Deputy service manager + benefit risk assessor (2 postings) — the non-clinical NHS pharmacist career stems
Why the 13 is structural — the ARRS pipeline
The middle-band plateau at 13 postings per sample is consistent with the Additional Roles Reimbursement Scheme (ARRS) funding cohort that NHS England PCNs operate. ARRS funds PCN clinical pharmacist posts at a fixed reimbursable salary band that lands squarely in the £42–49k range. PCNs don't typically post these roles at lower bands (ARRS reimburses to the cap) or higher bands (ARRS funding doesn't extend to Band 7 pay).
If the PCN clinical pharmacist pipeline is the main middle-band producer, then the stability at 13 reflects a steady-state ARRS hiring rate: roughly the same number of PCN clinical pharmacist roles turn over in the 14-day NHS Jobs freshness window at each measurement. With 1,300+ PCNs nationally and ARRS funding cycling through, ~13 live postings in the sample window is plausible as the national steady-state.
The cycle 19 sample reinforces this: 5 of the 13 middle-band roles explicitly name PCN or clinical pharmacist GP-practice work. A further 3 are foundation pharmacist roles at the Band 6 top (£46,580 = explicit Band 6 ceiling). The remaining 5 are specialist, non-clinical, or technician-adjacent roles that also happen to fall in the band.
The three-speed framing is now settled
The cycle 15 "three-speed pharmacist market" reframe (community / PCN-middle / NHS-clinical) replaced the earlier two-speed (community / NHS) story. After four confirming cycles, the three-speed framing is now the correct national pharmacist pay taxonomy:
| Tier | Range | Typical employer | Sample size per 200 |
|---|---|---|---|
| Community | £32–42k | Boots, Well, indies, supermarket | ~15 (cycle 15) |
| PCN / foundation middle | £42–49k | PCNs, GP practices, NHS foundation | 13 (four cycles) |
| NHS clinical / Band 7+ | £49k+ | NHS Trusts, HEE-linked roles | 63 (cycle 19) |
The 63-role £49k+ cohort is visible in the cycle 19 200-sample buckets (29 at £49–60k + 24 at £60–70k + 10 at £70k+). The 13-role middle band is flanked above and below by cleanly separated cohorts.
What this means for early-career pharmacists
If you're a UK pharmacist considering PCN clinical work versus NHS Trust clinical work or community retail, the middle band is a real career destination — not a transient artefact of Band 6/7 progression. You can expect to find ~13 live £42–49k postings on NHS Jobs at any given time, concentrated in PCN clinical pharmacist, foundation pharmacist, and independent prescriber roles. Geographic distribution is diffuse — the cycle 19 sample spans Peterborough, Newport, Milton Keynes, Harrow, Bodmin, Bodelwyddan, Middlesbrough, Crewe, London, Bradford and Watford.
The cycle 19 data doesn't support the earlier "bimodal market with no middle tier" framing. That framing was correct for community pharmacy viewed in isolation, but misleading for the combined UK pharmacist labour market including PCNs.
Explore the data
- NHS Jobs pharmacist search
- Three-speed pharmacist market
- Cycle 17 plateau first observation
- Pharmacist salary progression Band 5–8c
Methodology
Cycle 19 NHS Jobs sample: /api/jobs/search?source=NhsJobs&limit=200 fresh April 2026 pull. Salary buckets derived from the salary text field parsed for £NN,NNN values (annual only — hourly excluded). Mid-point bucketing used. The 200-item cap is approximately 38% of the current 519-item NHS Jobs total population; the middle-band count is a sample statistic, but the four-cycle consistency at exactly 13 is the signal-strengthening observation.